AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors.
Nakagawa M, Shimabe M, Watanabe-Okochi N, Arai S, Yoshimi A, Shinohara A, Nishimoto N, Kataoka K, Sato T, Kumano K, Nannya Y, Ichikawa M, Imai Y, Kurokawa M.
Nakagawa M, et al. Among authors: kumano k.
Blood. 2011 Dec 15;118(25):6626-37. doi: 10.1182/blood-2010-12-326710. Epub 2011 Oct 21.
Blood. 2011.
PMID: 22021368
Free article.